Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Astressin-B can reverse and prevent hair loss in stressed mice.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Fosravuconazole effectively treated a woman's scalp infection without side effects.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Cyclosporin promotes hair growth by boosting cell growth and reducing cell death.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Certain proteins can either protect against or increase the risk of hypertrophic scars.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Finasteride may help treat chronic CSC, improving vision.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

FLCN helps control iron levels in cells.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

FGF5 spliceosomes inhibit rabbit hair growth by affecting gene expression.